Located at the heart of one of the most bustling biotechnology, IT and energetics hubs in Poland, our 7,500 square meter R&D and production facility at the Gdansk Science and Technology Park is one of the most modern biotechnology centers in Europe. In Gdansk, we provide process development and GMP production of clinical and medium-scale commercial materials, supported by QC, QA and project management functions.
Customized formulations for drug product can also be developed in-house and subsequently tested for stability according to ICH standards. All processes, including fill & finish, can be scaled up and internally transferred to mammalian and microbial GMP-certified production facilities or to external partners. The facility utilizes scale-down models, as well as high-throughput mini and regular bioreactor systems for parallel screening.
Polpharma Biologics S.A.
Management Board: Jan Krzewiński, Adriana Kiędzierska-Mencfeld Polpharma Biologics S.A. with its registered office in Gdańsk, ul. Trzy Lipy 3, 80-172 Gdańsk, entered into the Register of Entrepreneurs maintained by District Court Gdańsk-North in Gdańsk, VII Commercial Division of the National Court Register, under number: 0000763945, VAT UE: PL9571112470, share capital of 695 000 000 PLN (paid in full), BDO register number: 000120346.
Located in Poland’s capital, Warsaw, and built to serve the growing global demand for biopharmaceuticals is our commercial-scale GMP production facility for drug substance. It is one of the largest and newest facilities of its kind in Europe.
The site adds significant drug substance manufacturing capacity for both commercial and clinical supply at 2,000 L scale and also includes a range of single use bioreactors from 50-500 L aimed at supporting clients with smaller capacity needs. This means we can support the increasing demand for early stage clinical trial material and orphan drugs at optimal costs.
3 x 500 L, 4 x 2,000 L
Expansion available to 30,000 L
Polpharma Biologics Warsaw Sp. Z o.o.
Management Board: Frank Ternes, Frederic Papp, Igor Kostyszyn, Wojciech Kowalski
Polpharma Biologics Warsaw sp. z o.o. with its registered seat in Ożarów Mazowiecki (05-850), Spółdzielcza 4, Duchnice, entered into Commercial Register maintained by District Court for capital city of Warsaw, its XIV Commercial Division of the National Court Register, under number: 0000498732, holder of a VAT UE identification number: PL 1182096979, statistical ID number: 147109384, share capital of 109.835.000 PLN (paid in full).
Located in the Utrecht Science Park, a hub for education, research, entrepreneurship and healthcare. The state-of-the-art facility focuses on the development of production cell lines for monoclonal antibodies (mAbs) and other proteins (including laboratory scale processes), as well as the generation of New Biological Entities (NBEs).
We currently employ around 50 personnel at the site, many are industry veterans in early stage development.
Polpharma Biologics Utrecht B.V.
Polpharma Biologics Utrecht B.V. is a company incorporated in The Netherlands and having its registered office at Yalelaan 46, 3584CM UTRECHT, The Netherlands, and registered by the Chamber of Commerce under the registration number (KVK) of 58858466